SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes inspection at Unit 3 manufacturing facility of Neuland Laboratories

27 May 2023 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection in Neuland Laboratories’ Unit 3 manufacturing facility, located at Gaddapotharam village, Jinnaram, Sangareddy District, from May 22, 2023 to May 26, 2023. The inspection has been concluded with 3 observations (minor) given under form 483, which are relating to procedures.

Neuland Laboratories is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs.


Neuland Laboratories Share Price

17177.50 225.25 (1.33%)
12-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.25
Dr. Reddys Lab 1273.90
Cipla 1388.80
Zydus Lifesciences 1104.35
Lupin 2292.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: